2 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Small Cell Lung Cancer ( SCLC ): new trials by email Literature Review of Small Cell Lung Cancer ( SCLC ) trials Research Report on Small Cell Lung Cancer ( SCLC )
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy benmelstobart in combination with anlotinib and etoposide - Small Cell Lung Cancer ( SCLC ) | Phase 3 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 64 | 2026-08-01 | 2026-07-27 |
| Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer Organoid Drug Sensitivity Testing-Guided Therapy, Topotecan - Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive-stage Small Cell Lung Cancer (SCLC) | Phase 2 / Phase 3 | Not yet recruiting | Peking Union Medical College Hospital | 128 | 2025-08-01 | 2025-08-06 |
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2)
Etoposide (1) · Topotecan (1) · anlotinib (1)
Peking Union Medical College Hospital (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)